Industry Trends

Asia Pacific Microsurgery Robot Market share was valued at USD 166.5 million in 2020 and is expected to witness 15.8% CAGR from 2021 to 2027.
 

Get more details on this report - Request Free Sample PDF

Rising demand for minimally invasive surgeries will surge the demand for microsurgery robot thereby, favouring the business growth. Minimally invasive surgery is highly efficient and possesses low-risk and is also safe and cost-effective. Owing to these advantages, minimally invasive surgical procedures are being adopted in several countries of Asia for improved and advanced patient care as well as management. Moreover, Intuitive Surgical has developed da Vinci single site technology that offers single incision surgical procedures, multiport, thus accelerating its adoption rate among patients and physicians. Reduced recovery time with the usage of minimally invasive microsurgery robot will create robust industry demand.  

Asia Pacific Market, By Application

The Asia Pacific application segment covers ureterorenoscopy, micro anastomosis, neurovascular surgery, ENT surgery, reconstructive surgery, urology surgery, ophthalmology surgery, neurovascular surgery, obstetrics and gynecology surgery, gastrointestinal surgery, oncology surgery, and others. Neurovascular surgery segment accounted for more than USD 4 million revenue size in 2020. Increasing cases of neurovascular diseases will drive the demand for microsurgery robot devices. Several healthcare professionals are increasingly relying on robotics for neurosurgical procedures owing to its numerous advantages. Several advantages include reduced blood loss, lower risk of transfusions, shorter hospitalization and reduced pain favouring the segmental growth.

Asia Pacific Market, By End-use

Get more details on this report - Request Free Sample PDF

The microsurgery robot end-use segment is divided into ambulatory surgical centers, research institutes, hospitals and clinics as well as others. The hospitals and clinics segment was valued over 50% market value in 2020. The segmental growth is attributed to increasing demand for microsurgery robot devices for various treatment of several diseases such as oncology, cardiovascular, neurovascular and others at hospital settings. All these major surgeries are performed at hospitals owing to its advanced medical infrastructure and availability of technologically upgraded microsurgery robot systems, augmenting the segmental progression.

Asia Pacific Market, By Country

The Japan microsurgery robot market held around 15.6% CAGR over the analysis timeframe. Surging prevalence of chronic and infectious disorders in Japan coupled with increasing healthcare expenditure will stimulate the country growth. Rise in healthcare expenditures will lead to consequent increase in the adoption of superior quality microsurgery robot devices. Similarly, growing investment in R&D activities to develop innovative surgical robotic systems for easy diagnosis and treatment will create positive impact on business growth.

Competitive Market Share

Some of the prominent players functioning in Asia Pacific market are TransEnterix Surgical, Stryker, Smith & Nephew, Zimmer Biomet, Auris Health (Johnson & Johnson), Medtronic, Corindus Inc. (Siemens Healthineers), Intuitive Surgical and Medrobotics Corporation. These industry players are adopting strategies such as expansion and product innovation to attract larger customer base and cater to the growing demand. For instance, in May 2018, Intuitive Surgical announced initiation of its independent operation in India. This strategy helped the company to increase its geographical presence.

Industry Background

The first recognized usage of robot-assisted surgical process began in 1985 and the Programmable Universal Machine for Assembly or Programmable Universal Manipulation Arm (PUMA) 560 robotic surgical arm was used in neurosurgical biopsy during that time. The 1985 robotic surgery resulted into the first laparoscopic process including robotic system, a cholecystectomy in 1987. In the 1990’s, the Automatic Endoscopic System for Optimal Positioning (AESOP) system manufactured by Computer Motion was the first system that received approval from the U.S. FDA for its endoscopic surgical method. Robots in healthcare industry already have a stunning 40 years history, yet there is an exceptional rise nowadays in clinical applications and new systems.